Tender Offer - SURMODICS INC

Form Type: DEF 14A

Filing Date: 2024-12-19

Corporate Action: Tender-offer

Type: New

Accession Number: 000095017024138240

Filing Summary: Surmodics, Inc. is undergoing a merger where they will be acquired for $43.00 per share in cash. This merger was approved by shareholders on August 13, 2024, and is expected to close in the second fiscal quarter of 2025, pending regulatory approval. The proxy statement outlines the agenda for the upcoming annual meeting on February 6, 2025, which includes the election of one Class II director and other governance matters. Shareholders who were recorded as of the cutoff date of December 12, 2024, are eligible to vote. The notice regarding proxy materials will similarly be sent to shareholders.

Document Link: View Document